Hae 2 Complex Dps 3 X Drops is a Health Canada–registered human drug (DIN 00757500) held by Thompson's Homeopathic Supplies Ltd., containing Aesculus Hippocastanum. Health Canada lists its status as Cancelled Post Market (status date 15 Jul 2009). Nexara Health has matched 16 registrations of Aesculus Hippocastanum across 2 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 00757500 |
|---|---|
| Brand name | Hae 2 Complex Dps |
| Active ingredient | Aesculus Hippocastanum |
| Strength | 3 X |
| Dosage form | Drops |
| Route | Oral |
| Company | Thompson's Homeopathic Supplies Ltd. |
| Status | Cancelled Post Market — 15 Jul 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Aesculus Hippocastanum registered in other markets
16 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Aesculus hippocastanum | Herbamed AG | Liquid | FDA NDC | ||
| Netherlands | Aesculus hippocastanum | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Aesculus hippocastanum | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Aesculus Hippocastanum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Aesculus Hippocastanum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hae 2 Complex Dps (DIN 00757500) marketed in Canada?
No. Health Canada lists DIN 00757500 as Cancelled Post Market as of 15 Jul 2009.
Who holds the Canadian licence for this product?
Thompson's Homeopathic Supplies Ltd. is the company of record in the Health Canada Drug Product Database.
Is Aesculus Hippocastanum registered outside Canada?
Yes — Nexara Health has matched 16 registrations in 2 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00757500, status date 2009-07-15; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00757500, status date 2009-07-15; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00757500, status date 2009-07-15; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.